Litcius/Paper detail

Safety Concerns with Nusinersen, Risdiplam, and Onasemnogene Abeparvovec in Spinal Muscular Atrophy: A Real-World Pharmacovigilance Study

Wei Zhuang, Mei Lu, Ye Wu, Zhehui Chen, Minying Wang, Xudong Wang, Shaoxing Guan, Wanlong Lin

2023Clinical Drug Investigation15 citationsDOI

Topics & Concepts

MedicinePharmacovigilanceSpinal muscular atrophyAdverse effectSMA*Odds ratioInternal medicinePediatricsCombinatoricsDiseaseMathematicsNeurogenetic and Muscular Disorders ResearchMuscle Physiology and DisordersAmyotrophic Lateral Sclerosis Research